Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study-Reference-Cited by-同舟云学术

Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study

Published:2015-10 Issue:13 Volume:16 Page:1370-1379
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

van Oers Marinus H J,Kuliczkowski Kazimierz,Smolej Lukáš,Petrini Mario,Offner Fritz,Grosicki Sebastian,Levin Mark-David,Gupta Ira,Phillips Jennifer,Williams Vanessa,Manson Stephanie,Lisby Steen,Geisler Christian

Publisher

Elsevier BV

Subject

Oncology

Reference25 articles.

1. Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?;Dreger;Blood,2014

2. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial;Salles;Lancet,2011

3. Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study;van Oers;J Clin Oncol,2010

4. Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials;Vidal;J Natl Cancer Inst,2011

5. Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL);Shanafelt;Blood,2013

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management;Journal of Clinical Medicine;2024-03-09

2. Maintenance therapy for chronic lymphocytic leukaemia;Cochrane Database of Systematic Reviews;2024-01-04

3. A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation;Expert Review of Hematology;2023-12-02

4. Infections in patients with chronic lymphocytic leukemia;Hematology, Transfusion and Cell Therapy;2023-07

5. Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice;Current Treatment Options in Oncology;2023-05-17